FDA Inspection 1270944 — Labena d.o.o.
The FDA completed an inspection of Labena d.o.o. on April 25, 2024 in Ljubljana. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 25, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ljubljana (Slovenia)
Additional Details
Mutual Recognition Agreement (MRA)